Natural cubic splines for the analysis of Alzheimer's clinical trials
Pharmaceutical Statistics · 2023-05 · 22 (3) · 508-519
DOI: 10.1002/pst.2285 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutical Statistics, online erschienen am 10.01.2023. Verfasst von Michael C Donohue und 9 weiteren Autor:innen. Beteiligte Einrichtung: Alzheimer's Therapeutic Research Institute, University of Southern California, San Diego, California, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, COVID-19. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, NCATS NIH HHS, National Institute on Aging.
Themen: Demenz
Abstract (Originalsprache)
Mixed model repeated measures (MMRM) is the most common analysis approach used in clinical trials for Alzheimer's disease and other progressive diseases measured with continuous outcomes over time. The model treats time as a categorical variable, which allows an unconstrained estimate of the mean for each study visit in each randomized group. Categorizing time in this way can be problematic when assessments occur off‐schedule, as including off‐schedule visits can induce bias, and excluding them ignores valuable information and violates the intention to treat principle. This problem has been exacerbated by clinical trial visits which have been delayed due to the COVID19 pandemic. As an alternative to MMRM, we propose a constrained longitudinal data analysis with natural cubic splines that treats time as continuous and uses test version effects to model the mean over time. Compared to categorical‐time models like MMRM and models that assume a proportional treatment effect, the spline model is shown to be more parsimonious and precise in real clinical trial datasets, and has better power and Type I error in a variety of simulation scenarios.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Alzheimer's Therapeutic Research Institute, University of Southern California, San Diego, California, USA.
- Department of Psychiatry, University of California, San Francisco, California, USA.
- Alzheimer's Disease Research Unit, Yale School of Medicine, New Haven, Connecticut, USA.
- Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA.
- Department of Internal Medicine-Geriatrics, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.
ORCID-Profile: Michael C Donohue
Förderung
- NIA NIH HHS
- NCATS NIH HHS
- National Institute on Aging
- ADNI
- National Institutes of Health
Zitieren
APA
Donohue, M. C., Langford, O., Insel, P. S., van Dyck, C. H., Petersen, R. C., Craft, S., Sethuraman, G., Raman, R., Aisen, P. S., & Alzheimer's Disease Neuroimaging Initiative (2023). Natural cubic splines for the analysis of Alzheimer's clinical trials. Pharmaceutical Statistics, 22(3), 508-519. https://doi.org/10.1002/pst.2285
Vancouver
Donohue MC, Langford O, Insel PS, van Dyck CH, Petersen RC, Craft S, et al. Natural cubic splines for the analysis of Alzheimer's clinical trials. Pharmaceutical Statistics. 2023;22(3):508-519. doi:10.1002/pst.2285
BibTeX
@article{Donohue2023,
author = {Donohue, Michael C and Langford, Oliver and Insel, Philip S and van Dyck, Christopher H and Petersen, Ronald C and Craft, Suzanne and Sethuraman, Gopalan and Raman, Rema and Aisen, Paul S and Alzheimer's Disease Neuroimaging Initiative, Alzheimer's Disease Neuroimaging Initiative},
title = {Natural cubic splines for the analysis of Alzheimer's clinical trials},
journal = {Pharmaceutical Statistics},
year = {2023},
volume = {22},
number = {3},
pages = {508--519},
doi = {10.1002/pst.2285}
}
EUVIMED